Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinoma. Clinical and experimental medicine 2025 https://researcherprofiles.org/profile/755918145 41137977 Núñez K, Sandow T, Burton J, Hibino M, Gimenez J, Cohen A, Mehta N, Thevenot P
